Cargando…
Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
BACKGROUND: Pulmonary arterial hypertension (PAH) is the leading cause of death in systemic sclerosis (SSc). Annual screening with echocardiogram (ECHO) is recommended. We present the methodological aspects of a PAH screening programme in a large Australian SSc cohort, the epidemiology of SSc-PAH in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341425/ https://www.ncbi.nlm.nih.gov/pubmed/28270192 http://dx.doi.org/10.1186/s13075-017-1250-z |
_version_ | 1782512987629682688 |
---|---|
author | Morrisroe, Kathleen Stevens, Wendy Sahhar, Joanne Rabusa, Candice Nikpour, Mandana Proudman, Susanna |
author_facet | Morrisroe, Kathleen Stevens, Wendy Sahhar, Joanne Rabusa, Candice Nikpour, Mandana Proudman, Susanna |
author_sort | Morrisroe, Kathleen |
collection | PubMed |
description | BACKGROUND: Pulmonary arterial hypertension (PAH) is the leading cause of death in systemic sclerosis (SSc). Annual screening with echocardiogram (ECHO) is recommended. We present the methodological aspects of a PAH screening programme in a large Australian SSc cohort, the epidemiology of SSc-PAH in this cohort, and an evaluation of factors influencing physician adherence to PAH screening guidelines. METHODS: Patient characteristics and results of PAH screening were determined in all patients enrolled in a SSc longitudinal cohort study. Adherence to PAH screening guidelines was assessed by a survey of Australian rheumatologists. Summary statistics, chi-square tests, univariate and multivariable logistic regression were used to determine the associations of risk factors with PAH. RESULTS: Among 1636 patients with SSc, 194 (11.9%) had PAH proven by right-heart catheter. Of these, 160 were detected by screening. The annual incidence of PAH was 1.4%. Patients with PAH diagnosed on subsequent screens, compared with patients in whom PAH was diagnosed on first screen, were more likely to have diffuse SSc (p = 0.03), be in a better World Health Organisation (WHO) Functional Class at PAH diagnosis (p = 0.01) and have less advanced PAH evidenced by higher mean six-minute walk distance (p = 0.03), lower mean pulmonary arterial pressure (p = 0.009), lower mean pulmonary vascular resistance (p = 0.006) and fewer non-trivial pericardial effusions (p = 0.03). Adherence to annual PAH screening using an ECHO-based algorithm was poor among Australian rheumatologists, with less than half screening their patients with SSc of more than ten years disease duration. CONCLUSION: PAH is a common complication of SSc. Physician adherence to PAH screening recommendations remains poor. Identifying modifiable barriers to screening may improve adherence and ultimately patient outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1250-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5341425 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53414252017-03-10 Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme Morrisroe, Kathleen Stevens, Wendy Sahhar, Joanne Rabusa, Candice Nikpour, Mandana Proudman, Susanna Arthritis Res Ther Research Article BACKGROUND: Pulmonary arterial hypertension (PAH) is the leading cause of death in systemic sclerosis (SSc). Annual screening with echocardiogram (ECHO) is recommended. We present the methodological aspects of a PAH screening programme in a large Australian SSc cohort, the epidemiology of SSc-PAH in this cohort, and an evaluation of factors influencing physician adherence to PAH screening guidelines. METHODS: Patient characteristics and results of PAH screening were determined in all patients enrolled in a SSc longitudinal cohort study. Adherence to PAH screening guidelines was assessed by a survey of Australian rheumatologists. Summary statistics, chi-square tests, univariate and multivariable logistic regression were used to determine the associations of risk factors with PAH. RESULTS: Among 1636 patients with SSc, 194 (11.9%) had PAH proven by right-heart catheter. Of these, 160 were detected by screening. The annual incidence of PAH was 1.4%. Patients with PAH diagnosed on subsequent screens, compared with patients in whom PAH was diagnosed on first screen, were more likely to have diffuse SSc (p = 0.03), be in a better World Health Organisation (WHO) Functional Class at PAH diagnosis (p = 0.01) and have less advanced PAH evidenced by higher mean six-minute walk distance (p = 0.03), lower mean pulmonary arterial pressure (p = 0.009), lower mean pulmonary vascular resistance (p = 0.006) and fewer non-trivial pericardial effusions (p = 0.03). Adherence to annual PAH screening using an ECHO-based algorithm was poor among Australian rheumatologists, with less than half screening their patients with SSc of more than ten years disease duration. CONCLUSION: PAH is a common complication of SSc. Physician adherence to PAH screening recommendations remains poor. Identifying modifiable barriers to screening may improve adherence and ultimately patient outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1250-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-07 2017 /pmc/articles/PMC5341425/ /pubmed/28270192 http://dx.doi.org/10.1186/s13075-017-1250-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Morrisroe, Kathleen Stevens, Wendy Sahhar, Joanne Rabusa, Candice Nikpour, Mandana Proudman, Susanna Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme |
title | Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme |
title_full | Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme |
title_fullStr | Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme |
title_full_unstemmed | Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme |
title_short | Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme |
title_sort | epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341425/ https://www.ncbi.nlm.nih.gov/pubmed/28270192 http://dx.doi.org/10.1186/s13075-017-1250-z |
work_keys_str_mv | AT morrisroekathleen epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme AT stevenswendy epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme AT sahharjoanne epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme AT rabusacandice epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme AT nikpourmandana epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme AT proudmansusanna epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme AT epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme |